Passage Bio, Inc. beat EPS estimates 0% of the time across 3 reported quarters (0 beats, 3 misses). Data sourced from SEC EDGAR.
| Quarter | EPS Estimate | EPS Actual | Surprise | Result |
|---|---|---|---|---|
| Q22026 FY2026 | $-2.20 | $-2.44 | -10.9% | Miss |
| Q12026 FY2026 | $-2.15 | $-2.36 | -9.8% | Miss |
| Q42025 FY2025 | $-2.19 | $-4.08 | -86.3% | Miss |
Back to PASG overview · PASG holders · PASG KPIs
Data sourced from U.S. SEC EDGAR filings. Not personalized investment advice.